Showing 921-930 of 1374 results for "".
- British Parliament Member Calls for BBLs to Be Suspendedhttps://modernaesthetics.com/news/british-parliament-member-calls-for-bbls-to-be-suspended/2473681/British Member of Parliament Dr. Simon Opher called for the suspension of Brazilian butt lift (BBL) procedures until more is known about their safety, following the death of a 33-year-old woman, the BBC reported. Alice Webb, a mother of five, underwent a nonsurgical BBL before falling u
- DefenAge 360-Rejuvenation Nail Root Serum Earns Allure Awardhttps://modernaesthetics.com/news/defenage-360-rejuvenation-nail-root-serum-earns-allure-award/2473680/DefenAge® Skincare’s 360-Rejuvenation Nail Root Serum earned a 2024 Allure Best of Beauty Award, DefenAge announced. “This recognition marks a significant milestone for the brand,” the company said in a press release, “solidifying its commitment to delivering
- Sofwave Promotes Menopause Awareness Monthhttps://modernaesthetics.com/news/sofwave-promotes-menopause-awareness-month/2473678/September is Menopause Awareness Month, and Sofwave is celebrating by reminding people of how much its technology can help women. “During menopause, there is a decrease in collagen and elastin production, which causes increased tissue laxity and wrinkles,” board-certified de
- Kenvue to Present New Data on Skincare Products at EADV Congresshttps://modernaesthetics.com/news/kenvue-to-present-new-data-on-skincare-products-at-eadv-congress/2473676/Kenvue announced the presentation of seven new data sets at the 2024 European Academy of Dermatology and Venereology (EADV) Congress this week in Amsterdam, Netherlands. The studies will feature Kenvue’s Aveeno and Neutrogena brands, “demonstrating the key to improved s
- Aerolase Art of Diversity Conference Continues Growinghttps://modernaesthetics.com/news/aerolase-art-of-diversity-conference-continues-growing/2473675/Aerolase’s third annual Art of Diversity conference in Jersey City, New Jersey, lived up to its name, with a diverse mix of practitioners and content that led to an engaging educational program. “The whole idea of the Art of Diversity for Skin Health is that there is an ecle
- Evolus to Ring Nasdaq Stock Market Closing Bell On September 13https://modernaesthetics.com/news/evolus-to-ring-nasdaq-stock-market-closing-bell-on-september-13/2473667/Evolus Inc. announced the company will be ringing the Nasdaq closing bell on Friday, September 13. The Nasdaq closing bell ceremony is a time-honored tradition, serving as a platform for companies to celebrate achievements and milestones. “We are honored to h
- Modern Aesthetics Board Member Reacts to FDA Clearance of New SkinPen Precision Elitehttps://modernaesthetics.com/news/modern-aesthetics-board-member-reacts-to-fda-clearance-of-new-skinpen-precision-elite/2473665/Crown Aesthetics announced the FDA clearance of its new SkinPen Precision Elite. The elevated device advances the SkinPen legacy and continues to position the brand as the highest standard in microneedling, the company said in a press release. "We are always looking for ways
- Hyperpigmentation Treatment Market Valued at $5.48Bhttps://modernaesthetics.com/news/hyperpigmentation-treatment-market-valued-at-548b/2473664/Hyperpigmentation is the darkening of the skin caused by the overproduction of melanin, leading to conditions such as melasma, post-inflammatory hyperpigmentation, and sunspots. The global hyperpigmentation treatment market was valued at approximately $5.48 billion in 2023, according to Ocean Rep
- Music City SCALE Hosts Exosomes Webinarhttps://modernaesthetics.com/news/music-city-scale-hosts-exosomes-webinar/2473659/The evolution of exosomes is fast-growing in the aesthetics industry. In an effort to provide practitioners with the latest research, Music City SCALE hosted a webinar called Exosomes – What’s the Buzz, What’s Real, and What’s Not on Tuesday, August
- Pre-Clinical Study for Regenerative Commercial-Sized Breast Implants Announcedhttps://modernaesthetics.com/news/pre-clinical-study-for-regenerative-commercial-sized-breast-implants-announced/2473655/The advancement of regenerative medicine continues to grow at a rapid pace. CollPlant Biotechnologies and Stratasys Ltd. announced the initiation of a pre-clinical study with 200cc commercial-sized regenerative implants printed on Stratasys Origin 3D printer. The collaboration is